Acute Leukemia Clinical Endpoints Will Be Topic Of FDA Public Workshop
This article was originally published in The Pink Sheet Daily
Executive Summary
The meeting is part of FDA's series on cancer clinical trial endpoints. The workshop, which will address clinical endpoints for acute lymphocytic and myeloid leukemia, will be held June 24 in Washington, D.C.